LX

LYO-X at Festival of Biologics 2026

Oct 13–15, 2026 Basel, Switzerland ~3k attendees Website

LYO-X takes part in 2 sessions at Festival of Biologics 2026 in Basel. Its program centres on antibodies for immunotherapy and on models that guide early clinical trials. It covers choosing the first human dose for antibody-drug conjugates and T cell engagers, using models of how a drug moves through and acts on the body.

OrganizationFestival of Biologics 2026 Attendance
LX
LYO-X
Consulting & services
Pharmacometrics consultancy offering PK/PD and quantitative systems pharmacology modelling for drug development.
Talk
Tue Oct 13
13:30
First in Human Dose Selection for ADCs and TCEs Using PK/PD and QSP
How computer models of drug behavior help pick safe yet active first human doses for antibody–drug conjugates and T cell engagers.
Clinical developmentADCs & armed antibodies
Chair
Tue Oct 13
16:45
Chair's Remarks
Antibodies for Immunotherapy

Explore the full Festival of Biologics 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Basel. Leave your work email and we’ll be in touch.

Privacy

Download the full Festival of Biologics 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from LYO-X

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by Terrapinn or the Festival of Biologics. Submit a correction